Revance Stock Buy Hold or Sell Recommendation

RVNC Stock  USD 3.64  0.01  0.27%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Revance is 'Cautious Hold'. Macroaxis provides Revance buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Revance positions.
  
Check out Revance Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.
In addition, we conduct extensive research on individual companies such as Revance and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Revance Buy or Sell Advice

The Revance recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Revance. Macroaxis does not own or have any residual interests in Revance or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Revance's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell RevanceBuy Revance
Cautious Hold

Market Performance

Very WeakDetails

Volatility

Very riskyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Revance has a Mean Deviation of 3.53, Standard Deviation of 7.41 and Variance of 54.88
We provide trade recommendations to complement the recent expert consensus on Revance. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Revance is not overpriced, please check all Revance fundamentals, including its cash flow from operations, total asset, and the relationship between the total debt and target price . Given that Revance has a price to earning of (7.60) X, we recommend you to check out Revance market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Revance Trading Alerts and Improvement Suggestions

Revance generated a negative expected return over the last 90 days
Revance has high historical volatility and very poor performance
Revance has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 234.04 M. Net Loss for the year was (323.99 M) with profit before overhead, payroll, taxes, and interest of 103.69 M.
Revance currently holds about 233.82 M in cash with (216.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.2.
Revance has a poor financial position based on the latest SEC disclosures
Over 88.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3

Revance Returns Distribution Density

The distribution of Revance's historical returns is an attempt to chart the uncertainty of Revance's future price movements. The chart of the probability distribution of Revance daily returns describes the distribution of returns around its average expected value. We use Revance price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Revance returns is essential to provide solid investment advice for Revance.
Mean Return
-0.27
Value At Risk
-6.76
Potential Upside
12.30
Standard Deviation
7.41
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Revance historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Revance Stock Institutional Investors

Shares
Geode Capital Management, Llc2024-09-30
2.3 M
Lmr Partners Llp2024-09-30
2.2 M
D. E. Shaw & Co Lp2024-09-30
1.9 M
Qube Research & Technologies2024-09-30
1.9 M
Omni Event Management Ltd2024-09-30
1.7 M
Palo Alto Investors, Llc2024-09-30
1.6 M
Cnh Partners, Llc2024-09-30
1.4 M
Madison Avenue Partners, Lp2024-09-30
1.4 M
Hsbc Holdings Plc2024-09-30
1.2 M
Blackrock Inc2024-09-30
8.7 M
Vanguard Group Inc2024-09-30
5.7 M
Note, although Revance's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Revance Cash Flow Accounts

202020212022202320242025 (projected)
Change In Cash165.1M(221.3M)(652K)29.7M26.8M28.1M
Free Cash Flow(182.7M)(239.6M)(216.6M)(223.5M)(201.1M)(191.1M)
Depreciation10.3M19.9M39.1M13.7M15.7M8.5M
Other Non Cash Items19.6M1.2M70.7M89.8M103.3M108.4M
Capital Expenditures4.2M18.1M23.0M6.9M7.9M7.3M
Net Income(282.1M)(281.3M)(356.4M)(324.0M)(291.6M)(277.0M)
End Period Cash Flow337.0M115.7M115.0M144.7M166.5M145.2M
Investments272.4M(11.6M)(138.8M)148.3M170.6M179.1M
Net Borrowings(1.3M)(742K)249.4M87.1M100.1M50.4M
Change To Netincome18.7M46.8M43.4M121.2M139.4M146.3M

Revance Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Revance or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Revance's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Revance stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.34
β
Beta against Dow Jones0.67
σ
Overall volatility
6.91
Ir
Information ratio -0.05

Revance Volatility Alert

Revance is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Revance's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Revance's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Revance Fundamentals Vs Peers

Comparing Revance's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Revance's direct or indirect competition across all of the common fundamentals between Revance and the related equities. This way, we can detect undervalued stocks with similar characteristics as Revance or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Revance's fundamental indicators could also be used in its relative valuation, which is a method of valuing Revance by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Revance to competition
FundamentalsRevancePeer Average
Return On Equity-20.97-0.31
Return On Asset-0.24-0.14
Profit Margin(0.72) %(1.27) %
Operating Margin(0.54) %(5.51) %
Current Valuation679.35 M16.62 B
Shares Outstanding104.39 M571.82 M
Shares Owned By Insiders8.55 %10.09 %
Shares Owned By Institutions87.89 %39.21 %
Number Of Shares Shorted4.51 M4.71 M
Price To Earning(7.60) X28.72 X
Price To Book12.30 X9.51 X
Price To Sales1.47 X11.42 X
Revenue234.04 M9.43 B
Gross Profit103.69 M27.38 B
EBITDA(290.64 M)3.9 B
Net Income(323.99 M)570.98 M
Cash And Equivalents233.82 M2.7 B
Cash Per Share3.20 X5.01 X
Total Debt478.43 M5.32 B
Debt To Equity2.94 %48.70 %
Current Ratio3.38 X2.16 X
Book Value Per Share(1.55) X1.93 K
Cash Flow From Operations(216.57 M)971.22 M
Short Ratio1.70 X4.00 X
Earnings Per Share(3.34) X3.12 X
Price To Earnings To Growth(0.64) X4.89 X
Target Price7.72
Number Of Employees59718.84 K
Beta0.95-0.15
Market Capitalization378.94 M19.03 B
Total Asset478.45 M29.47 B
Retained Earnings(2.08 B)9.33 B
Working Capital249.64 M1.48 B
Note: Disposition of 120000 shares by Hollander David of Revance subject to Rule 16b-3 [view details]

Revance Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Revance . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Revance Buy or Sell Advice

When is the right time to buy or sell Revance? Buying financial instruments such as Revance Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Revance in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Coal Thematic Idea Now

Coal
Coal Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:
Check out Revance Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.34)
Revenue Per Share
2.656
Quarterly Revenue Growth
0.107
Return On Assets
(0.24)
Return On Equity
(20.97)
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.